Foresight Autonomous Holdings Ltd is a technology company engaged in the development of 3D perception systems and cellular-based applications... Show more
Foresight Autonomous Holdings Ltd. is an Israeli technology company headquartered in Ness Ziona that develops advanced three-dimensional (3D) perception systems and cellular-based applications. Through its subsidiaries Foresight Automotive, Foresight Changzhou Automotive, and Eye-Net Mobile, the company offers both "in-line-of-sight" vision systems and "beyond-line-of-sight" accident-prevention solutions. Its flagship QuadSight platform is a four-camera multi-spectral vision solution combining stereoscopic infrared and visible-light cameras, while Eye-Net Mobile provides vehicle-to-everything (V2X) collision-prevention technology delivered through smartphones and other connected devices. These solutions target automotive, defense, autonomous driving, agriculture, heavy industrial equipment, and unmanned aerial vehicle markets. Investors follow FRSX for its exposure to AI-based perception, autonomous mobility, and defense-security themes, though the company remains pre-profit and generates only modest commercial revenue.
Over the last 30 days, FRSX fell from a closing price of $1.07 on October 5, 2026, to approximately $0.65 in early November, a decline of roughly 39%. The move was not a single-day event but a steady grind lower punctuated by elevated-volume sessions, including a spike of more than four million shares traded on October 13, 2026. The stock's 30-day decline aligns with broader third-party readings showing a roughly 39% drop over the trailing four weeks.
The last quarter tells a similar but steeper story. From about $1.31 in early August, shares fell to near $0.65, representing a decline of approximately 50%. Throughout the period, FRSX traded below both its 50-day and 200-day moving averages, reflecting sustained technical weakness and a persistent downtrend rather than an isolated correction.
Several verified developments shaped the 30-day decline. On September 30, 2026, Foresight announced a voluntary delisting of its ordinary shares from the Tel Aviv Stock Exchange (TASE), with the final trading day set for January 1, 2027. A follow-up reminder issued on November 2 encouraged holders to convert ordinary shares into Nasdaq-traded American Depositary Shares, a transition that introduced uncertainty and conversion-related selling pressure.
Days earlier, on September 28, the company entered a non-binding term sheet to acquire a 50.01% controlling interest in a developer of data-center projects in Poland with planned capacity of up to 270 megawatts. The proposed transaction, which included a related-party element because the company's CFO holds a stake in the target, prompted investor questions about a strategic pivot away from its core perception business. Separately, the terms of the previously announced VisionWave Holdings transaction—an exchange that would issue VisionWave roughly 46% of Foresight's shares—continued to weigh on the share count and valuation outlook. Combined with second-quarter results that showed quarterly revenue of $86,000 and a GAAP net loss of about $2.8 million, these factors reinforced a risk-off stance toward the thinly traded micro-cap.
The quarterly decline reflects a longer-running repricing. In June 2026, Foresight executed a definitive agreement under which VisionWave Holdings (VWAV) would acquire up to 52% of Foresight through a staged share exchange valued at about $17.5 million in VisionWave stock, implying a post-investment valuation near $34 million. The transaction contemplates issuing newly created ordinary shares representing 46% of the company at the Stage 1 closing, a meaningful dilution signal for existing holders. Earlier in the year, Foresight also completed a one-for-three reverse split and ADS ratio change effective February 26, 2026, to help maintain Nasdaq listing compliance. Together with weak financial results and a rotation away from speculative AI-mobility names, these structural and dilution-related developments drove the stock's multi-month decline.
For investors seeking a more systematic approach to market volatility, Tickeron's Trending AI Robots page offers a curated view of AI-driven trading bots. Tickeron provides hundreds of AI trading bots that monitor thousands of tickers, but only the top-performing and most relevant strategies appear in this featured section. The bots vary by trading style, holding timeframe, and performance metrics, allowing users to compare approaches across different risk profiles and market conditions. The section is designed to surface currently active, high-relevance strategies, giving traders a starting point for evaluating algorithmic trading tools alongside their own research.
Looking ahead, investors should monitor several key factors. The completion of the VisionWave Stage 1 exchange remains subject to regulatory approvals, Nasdaq listing requirements, and other closing conditions, and its outcome will directly affect share count and control. The TASE delisting is scheduled to conclude on January 4, 2027, with a January 7, 2027 deadline for fee-free conversions to ADSs. The proposed Polish data-center acquisition remains non-binding and depends on due diligence, an independent valuation, and definitive documentation. Additionally, upcoming quarterly results, progress on commercialization agreements and proof-of-concept programs such as the Zeda Korea road-safety initiative, and any updates on Eye-Net's V2X deployments will help determine whether the company can stabilize revenue and sentiment. As with any micro-cap development-stage company, dilution risk, cash-burn, and execution uncertainty remain central considerations.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where FRSX declined for three days, in 358 of 385 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for FRSX entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where FRSX advanced for three days, in 148 of 193 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
FRSX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.319) is normal, around the industry mean (0.781). P/E Ratio (-0.081) is within average values for comparable stocks, (39.881). Projected Growth (PEG Ratio) (0.620) is also within normal values, averaging (1.494). Dividend Yield (0.046) settles around the average of (0.043) among similar stocks. P/S Ratio (9.643) is also within normal values, averaging (49.456).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. FRSX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRSX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of residential and commercial real estate properties
Industry AutoPartsOEM